- Research article
- Open Access
Proteomic analysis of blastema formation in regenerating axolotl limbs
BMC Biology volume 7, Article number: 83 (2009)
Following amputation, urodele salamander limbs reprogram somatic cells to form a blastema that self-organizes into the missing limb parts to restore the structure and function of the limb. To help understand the molecular basis of blastema formation, we used quantitative label-free liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)-based methods to analyze changes in the proteome that occurred 1, 4 and 7 days post amputation (dpa) through the mid-tibia/fibula of axolotl hind limbs.
We identified 309 unique proteins with significant fold change relative to controls (0 dpa), representing 10 biological process categories: (1) signaling, (2) Ca2+ binding and translocation, (3) transcription, (4) translation, (5) cytoskeleton, (6) extracellular matrix (ECM), (7) metabolism, (8) cell protection, (9) degradation, and (10) cell cycle. In all, 43 proteins exhibited exceptionally high fold changes. Of these, the ecotropic viral integrative factor 5 (EVI5), a cell cycle-related oncoprotein that prevents cells from entering the mitotic phase of the cell cycle prematurely, was of special interest because its fold change was exceptionally high throughout blastema formation.
Our data were consistent with previous studies indicating the importance of inositol triphosphate and Ca2+ signaling in initiating the ECM and cytoskeletal remodeling characteristic of histolysis and cell dedifferentiation. In addition, the data suggested that blastema formation requires several mechanisms to avoid apoptosis, including reduced metabolism, differential regulation of proapoptotic and antiapoptotic proteins, and initiation of an unfolded protein response (UPR). Since there is virtually no mitosis during blastema formation, we propose that high levels of EVI5 function to arrest dedifferentiated cells somewhere in the G1/S/G2 phases of the cell cycle until they have accumulated under the wound epidermis and enter mitosis in response to neural and epidermal factors. Our findings indicate the general value of quantitative proteomic analysis in understanding the regeneration of complex structures.
With the exception of cervid antlers [1, 2], terminal phalanges of humans and rodents [3–5], and ear tissue of certain strains of mice and rabbits, [6, 7], mammalian appendages do not regenerate after amputation. By contrast, urodele salamanders have the unique natural ability to regenerate appendages from any level of amputation by the formation of a blastema that subsequently self-organizes into the amputated limb parts [8–10]. After amputation, proteolysis of extracellular matrix (ECM) liberates muscle, skeletal, connective tissue, and peripheral nerve Schwann cells from their tissue organization . The liberated cells dedifferentiate and migrate under the wound epidermis to form an avascular accumulation (also called early bud) blastema [12–14]. In addition, satellite cells contribute to muscle formation in the blastema [15, 16], and it would not be surprising if mesenchymal stem cells of the periosteum and endosteum contributed to the blastema as well. Blastema cells morphologically resemble mesenchymal stem-like cells, although their surface antigens and other biomarkers are incompletely characterized. Once formed, the accumulation blastema is enlarged to the medium bud stage and beyond by a marked increase in mitosis [17–23]. Sustained mitosis of blastema cells, but not dedifferentiation, is dependent on factors from the wound epidermis  and regenerating nerves . Histological [17, 18], cell marking [25, 26] and genetic marking  studies indicate that blastema cells derived from each tissue redifferentiate into the same tissue, although some cells derived from the dermis differentiate into cartilage as well.
Analysis of the molecular mechanisms of blastema formation in the urodele limb is useful for understanding how we might achieve the goal of mammalian regeneration in situ by chemical induction . The traditional approach to molecular research on amphibian limb regeneration has been to characterize the expression patterns and functional roles of single genes expressed during embryonic limb development. A large number of genes have been studied in this way, particularly genes involved in pattern formation [10, 29, 30]. Less biased and more global analyses have recently been conducted using subtractive hybridization and microarrays to compare transcriptional profiles of regenerating versus intact limb tissues, or to compare blastemas of regeneration-competent versus regeneration-deficient limbs [31–35].
A number of studies have been carried out on protein synthesis and separation in regenerating urodele limbs. Autoradiographic studies of C14 methionine, S35 thioamino acids or C14 leucine incorporation revealed intense protein synthesis throughout regeneration [36–41]. Several protein separation analyses have been carried out using one-dimensional or two-dimensional gel electrophoresis [42–45]. These resolved up to 800 individual proteins  and revealed differences in protein composition at succeeding stages of regeneration in normal [43, 44] and denervated limbs , although few proteins were identified.
Protein separation and identification technology has evolved rapidly in the past 5 years with the introduction of label-free liquid chromatography/mass spectrometry methods that can more accurately identify and quantify peptide species. Also, with the development of expressed sequence tag (EST) databases [46, 47], it is possible to annotate short peptide sequences to protein models. Here, we report the application of this technology to analyze the formation of the accumulation blastema in regenerating axolotl hind limbs. Our results confirm a number of earlier studies on signaling, cytoskeletal and ECM changes, and metabolism. They also suggest that the amputated urodele limb uses a combination of mechanisms to regulate apoptosis during blastema formation that might be essential for dedifferentiation. Lastly, we have identified a highly upregulated centrosomal cell cycle-related oncoprotein, ecotropic viral integrative factor 5 (EVI5), that may play a key role in preventing dedifferentiated cells from entering mitosis until an accumulation blastema has formed.
Figure 1 shows the histological appearance of regenerating limbs in longitudinal section at 1, 4 and 7 dpa. At 1 dpa, the wound epidermis, including gland cells, has migrated to cover the wound. Clotted plasma, muscle fragments, cellular debris and lymphocytes are present under the wound epidermis, which is 3 to 4 cells thick. At 4 dpa, histolysis is liberating cells from their tissue organization and blastema cells have begun to accumulate under the wound epidermis. Osteoclasts can be seen eroding the matrix of the periosteal bone shell that surrounds the cartilage. The basement membrane under the wound epidermis is absent and the wound epidermis is in direct contact with the underlying tissues. By 7 dpa, further histolysis and distal migration of dedifferentiated cells has produced an avascular accumulation blastema with a cell density distinctly higher than that of the more proximal tissue. Examination of serial sections revealed few mitotic figures from 1 to 7 dpa. Some pyknotic nuclei were observed at 1 dpa, but not at 4 and 7 dpa, suggesting a minimum of cell death during the latter time frame.
A total of 1,624 peptides were separated in the samples. In all, 138 from priority 1 and 285 peptides from priority 2 were statistically significant (Additional file 1). Of these 423 statistically significant peptides, 114 peptides were not analyzed further for the reasons outlined in Methods. A total of 309 proteins (Additional file 2) were analyzed for their role in biological processes. A comparison of non-redundant peptide sequences (N = 405) with the axolotl EST database identified 149 perfect-match peptides (36.8%) that were 100% identical to a translated EST contig from either Ambystoma mexicanum or the closely related Ambystoma tigrinum. These proteins are shown in bold in Additional file 1.
Figure 2 stratifies the proteins according to biological process, molecular function and cellular location. Figure 3 is a global intensity map of fold changes at 1, 4 and 7 dpa. The peptides were grouped into 10 biological process categories (see Additional file 2): (1) signaling, (2) Ca2+ binding and translocation, (3) transcription, (4) translation, (5) cytoskeleton, (6) ECM, (7) metabolism, (8) cell protection, (9) degradation, and (10) cell cycle. Table 1 summarizes the ratios of the numbers of proteins upregulated (U) to downregulated (D) relative to controls (U/D ratios) at 1, 4, and 7 dpa for each category of biological process. Table 2 lists those proteins with positive or negative fold changes greater than two with respect to controls, and which may thus have special biological significance. Below, we describe the results for each of the 10 biological categories in order, with those proteins upregulated or downregulated by a factor of 2.0 or more at any time point shown in bold type.
A key intracellular signaling pathway is the inositol triphosphate/diacylglycerol (IP3/DAG) pathway. IP3 and DAG are cleavage products of phosphatidylinositol-4, 5-bisphosphate (PIP2). A precursor to PIP2 is myoinositol (inositol). Inositol-3-phosphate synthase 1 (ISYNA1) is a key enzyme in the synthesis of inositol from glucose-6-phosphate, and it was upregulated on all dpa. Two regulators of Rho-type guanosine triphosphatases (GTPases) were detected. SYDE2, a GTPase activator, was upregulated at 4 dpa, but downregulated at 1 and 7 dpa, while NET1, a guanine nucleotide exchange factor, was upregulated on all dpa.
Several proteins involved in endocytotic trafficking were identified. CLTCL1, the major protein of the coat of coated pits and vesicles, was downregulated on all dpa. By contrast, ITSN2, which may regulate the formation of clathrin-coated vesicles, was upregulated on all dpa. Several Rab GTPases and associated factors exhibited differential regulation. The Rab family is involved in vesicular trafficking and signaling. RAB6B was upregulated on all dpa and ARL1 and XG28K were downregulated at 1 dpa and upregulated at 7 dpa. A Rab GTPase activator, TBCK, was upregulated at 4 and 7 dpa, while another, TBC1D17, was downregulated on all dpa. GDI2, which regulates the exchange reaction of most Rab proteins by inhibiting the dissociation of guanidine dihydrogen phosphate (GDP) from them, was downregulated at 1 dpa, then returned to control value at 4 and 7 dpa.
Other signaling-related proteins that were upregulated on all three or two of three dpa were: (1) EZR, a peripheral membrane protein that may act to organize transmembrane receptors and binds to signal transduction molecules such as phosphoinositol 3 (PI3) kinase, (2) the receptor for nicotinic acid GPR109B, (3) IRS4, which interfaces between many growth factors and intracellular signaling molecules, (4) TYK2, which phosphorylates receptors of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway to transduce cytokine signals, (5) guanine nucleotide binding protein β polypeptide 2-like 1 (GNB2L1), which anchors protein kinase C to the cytoskeleton, (6) EPHA7, the receptor for the A1 to 5 members of the ephrin A family of ligands, and (7) neuronal nitric oxide synthase (NOS1), the enzyme that synthesizes nitric oxide (NO), a gas with a wide variety of signaling functions. Of all the proteins detected, NOS1 exhibited the highest upregulation at 1 dpa (4.93), after which the level of upregulation declined below 2.0 at 4 and 7 dpa. PPP2CB, the catalytic subunit for phosphatase 2A, a major serine/threonine phosphatase implicated in the negative control of cell growth and division, was downregulated at 1 and 4 dpa, and upregulated at 7 dpa. YWHAZ, an adaptor protein that mediates signal transduction by binding to phosphoserine-containing proteins, was also downregulated at 1 and 4 dpa, with no change at 7 dpa. Another adaptor protein, YWHAE, as well as IRF6.2 and tyrosine-protein kinase 6 (PTK6), were downregulated at all dpa. PTK6 is a cytoplasmic protein kinase that may function as an intracellular signal transducer in epithelia.
Five proteins associated with Wnt signaling were detected. Wnt8a, a ligand for the canonical Wnt pathway, was upregulated on all three dpa. Adenomatous polyposis coli (APC), part of the complex that destabilizes β-catenin in the canonical pathway was upregulated at 4 and 7 dpa. CCDC88C, a Disheveled-binding protein that negatively regulates the canonical pathway, was upregulated on all dpa, while DIXDC1, a positive effector of the canonical pathway, was downregulated on all dpa. Inversin (INVS), which acts to switch Wnt signaling from the canonical to the non-canonical pathway by targeting the Disheveled protein for degradation by the ubiquitin proteasome, was upregulated at 4 and 7 dpa.
Two olfactory receptors were detected, with opposite fold change. OR2AT4 was upregulated on all dpa, whereas OR4D10 was downregulated on all dpa. Follicle stimulating hormone receptor (FSHB) was also upregulated on all days. The potential functions of these proteins in limb regeneration are unknown. The latent transforming growth factor (TGF)β-binding protein was upregulated at 7 dpa, and ectodermin (ECTO), a SMAD4 ubiquitin ligase that attenuates the TGFβ response was downregulated on all dpa.
Ca2+binding and translocation proteins
The cell maintains cytosolic calcium homeostasis by channels that translocate Ca2+ between the cytosol and the endoplasmic reticulum (ER) or sarcoplasmic reticulum (SR), and between the inside and outside of the cell. Overall, the patterns of fold change for Ca2+-binding proteins suggest a significant increase in cytosolic Ca2+ during blastema formation. Channel proteins in the plasma membrane that mediate extracellular Ca2+ influx into the cytosol were upregulated on all dpa (CACNA1A, ATP11A) or at 7 days (CACNA2D3), while proteins that translocate Ca2+ from the cytosol to the ER/SR (ATP2A3, SRL, ASPH), or buffer cytosolic Ca2+ during muscle contraction (PVALB) were downregulated on all dpa. CAMK2D, a kinase that regulates transport of Ca2+ into and out of cells, was downregulated at 4 and 7 dpa. Another kinase that is covalently linked to ion channels and regulates Ca2+ influx is heart α-protein kinase (HAK), which was downregulated at 1 and 4 dpa, but strongly upregulated at 7 dpa. MYLC2PL, a mitochondrial Ca2+ binding myosin light chain, was downregulated on all dpa. By contrast, CASQ1, which complexes to Ca2+ for storage in the ER/SR and mitochondria, was upregulated on all dpa. Another protein upregulated at 4 and 7 dpa was the Ca2+ binding mitochondrial solute carrier (SLC25A24), which shuttles metabolites, nucleotides and cofactors through the mitochondrial inner membrane.
An interesting group of calcium/phospholipid-binding proteins was the annexins. ANXA1, which is thought to reduce inflammation and promote fibrinolysis, was downregulated at 1 and 4 dpa. ANXA2 was upregulated at 1 and 4 dpa and ANXA4 and 6 were upregulated at 7 dpa. ANXA2 is an autocrine factor that promotes osteoclast formation and bone resorption, and ANXA4 and 6 promote exocytosis in epithelial cells.
A total of 58 proteins were associated with transcription. Changes in 14 chromatin-associated proteins were detected. In all, 10 of these were H1 and H2 histones, with four being upregulated on all dpa and two downregulated at all dpa. Another was upregulated at 1 dpa, returning to control level at 7 dpa. Of the remaining three histones, one was upregulated at 1 and 4 dpa before returning to control level at 7 dpa, another was downregulated at 1 and 4 dpa, but was upregulated at 7 dpa and the other showed no change at 1 dpa, then was downregulated at 4 and 7 dpa. Two proteins that regulate gene expression by covalent modification of histone proteins (MTA1) and nucleosome assembly (NAP1L1-A) were upregulated on all dpa and at 4 and 7 dpa, respectively. JMJD1B (Jumonji domain), a lysine-specific histone demethylase, was downregulated at all dpa (over sixfold at 7 dpa). Hairless (HR), a Jumonji domain-containing transcription factor that recruits histone acetylases to repress transcription, was upregulated at 1 and 4 dpa, and downregulated at 7 dpa.
Of the transcription-associated proteins, 21 were transcription factors. The majority of these were upregulated at all three or two of three dpa, particularly at 4 and 7 dpa. Of six factors expected to act in a general fashion, CBTF122, a subunit of the Xenopus laevis CCAAT box transcription factor, was the only one upregulated on all dpa. SND1 and TRIM29 were downregulated at 1 dpa but upregulated at 7 dpa while E4F1 and TAF4 were downregulated at 1 and 4 dpa and upregulated at 7 dpa. ATF1 was downregulated on all dpa. FUBP1, an ATP-dependent DNA helicase that stimulates c-myc expression in undifferentiated cells was upregulated at 7 dpa. MNT, an E-box (CANNTG) binding transcriptional repressor of c-myc was upregulated at 1 dpa, but downregulated at 4 and 7 dpa.
Six zinc finger transcription factors designated by number were noted, four of which were upregulated at all, or two of three dpa. Of the other two, ZNF777 was downregulated on all dpa, and ZNF559 was downregulated at 1 and 4 dpa, and then upregulated at 7 dpa. The Kruppel-like factor 6 is a ubiquitously expressed zinc finger tumor suppressor that was upregulated at 1 and 4 dpa, and then downregulated at 7 dpa. Several factors (AHCTF1, nuclear receptor subfamily 2, group C member 2 (NR2C2), nuclear factor of activated T-cells cytoplasmic 4 (NFATC4), sex determining region Y box 6 (SOX6), and LIN28 that were upregulated on all, or two of three dpa, induce transcription of specific sets of genes. For example, NR2C2 is a nuclear receptor for mineralocorticoids and glucocorticoids, NFATC4 plays a role in inducing cytokine gene expression in T cells, and SOX6 is required for neurogenic and skeletal differentiation. LIN28 is a transcription factor active in embryonic stem cells . NEUROD2, a neuronal differentiation factor, was downregulated on all dpa.
In all, 23 of the transcriptional proteins were associated with mRNA processing. At 1 and 4 dpa, downregulation predominated over upregulation. By 7 dpa, however, the U/D ratio was 1.5. The majority of the processing proteins were heterogeneous nuclear ribonucleoproteins, small nuclear riboproteins, and splicing factors. One of these proteins, CWC15, was downregulated over threefold at 7 dpa. Two DEAD box helicases, which unwind RNA structure for accessibility by splicing enzymes, were detected. DEAD box polypeptide 10 (DDX10) was upregulated on all dpa, while DDX46 was upregulated at 1 dpa and downregulated at 4 and 7 dpa. MATR3 anchors mRNA to the nuclear matrix, and was upregulated on all dpa. RBM, a RNA-binding protein of unknown function, was upregulated at 4 and 7 dpa.
Many of the 20 proteins involved in translation, particularly ribosome structural proteins, were upregulated. We detected 13 ribosome structural proteins, about evenly divided between the 60S and 40S subunits. Two of these, RPL7L1 and RPS20, were upregulated at all the time points. Factors for initiation (PABPC1), binding of mRNA to the ribosome (E1F4B), and translocation of nascent protein from the A site to the B site of the ribosome (EEF2) were downregulated or unchanged at 1 dpa, but were upregulated at 4 and 7 dpa. Another initiation factor, E1F4A1, was downregulated at 1 dpa, returned to control level at 4 dpa, and was upregulated at 7 dpa. The elongation factor EEF1A2 was upregulated on all dpa. TARSL2, which is involved in tRNA aminoacylation, was upregulated at 1 dpa, and downregulated at 4 and 7 dpa. Lastly, a translation termination factor, ETF1, was upregulated at 4 and 7 dpa.
About one-third of the cytoskeletal proteins were sarcomeric proteins of skeletal muscle, and these were heavily downregulated. Many, such as TNNT3A, TM7, myosin light chain 3 (MYL3) and MYL5, were downregulated at all the time points.
Of the 40 non-sarcomeric proteins, 25 had functions related to cell motility and maintenance of cell shape and structural integrity. The U/D ratio of these proteins strongly favored downregulation at 1 dpa, but the ratio shifted in favor of upregulation at 4 and 7 dpa. Proteins that were downregulated on all dpa were ACTN1 and 4, GOLGA1, PLS3, XAK-B, and cytokeratin type II. Proteins downregulated at 1 and 4 dpa were desmoplakin isoform II, KRT 12 and KRT5.5. NAV1 was upregulated at all dpa. Seven proteins, FLNB, SYNE2, TUBA, TUBA4B, KRT 19, ACTR2-A and TUBB2C, were downregulated or showed no change at 1 dpa, then were upregulated at 4 and 7 dpa. The remaining proteins MYO9A, MYH9, ACTG1, TUBB4, desmoplakin (DSP), XAK-C and EPPK1, showed a mixture of fold change patterns.
In all, 10 proteins are involved in intracellular movement. MYO1C and MYO5A were downregulated at 1 and 4 dpa, but upregulated at 7 dpa. DYNC1LI2 was upregulated at 1 and 4 dpa, but downregulated at 7 dpa, DNAH3 was downregulated at 4 and 7 dpa, and DYNLL1 was downregulated on all dpa. MYH1 was upregulated at 1, then downregulated at 4 and 7 dpa. MYO1E was upregulated at 1 dpa, downregulated at 4 dpa, and returned to control level at 7 dpa. Two proteins that move or anchor kinases to the cytoskeleton (PDLIM1, PALM2) were downregulated at 4 and 7 dpa. The major vault protein (MVP), which may act as a scaffold for kinases involved in signal transduction and may also play a role in nucleocytoplasmic transport, was downregulated at 1 and 4 dpa, returning to control level at 7 dpa.
There were five adhesion proteins. CDH5 (vascular endothelial cadherin), SCARF2, and ST3GAL5, a type II membrane protein that also maintains fibroblast morphology, were upregulated at all dpa, while CNTNAP4 and FHDC1were downregulated at all dpa.
Of the remaining five non-sarcomeric proteins, KPNA2, which is involved in the import of nuclear proteins, and MYOF, a Ca2+/phospholipid-binding protein that promotes rapid resealing of damaged endothelial cell membranes, were downregulated on 4 and 7 dpa. Sorbin (SORBS1), which plays a role in insulin-stimulated glucose transport, was downregulated on all dpa. By contrast, piccolo (PCLO), which organizes the cytoskeleton in synaptic zones, and PMFBP1, a general cytoskeletal organizing protein, were upregulated at all dpa.
Components of collagen 1 and collagen 13 were upregulated at all or two of three dpa. Collagen 5 was upregulated at 1 and 4 dpa, and then downregulated at 7 dpa. Components of cartilage matrix (collagen 2) and basement membrane (collagen 4) were downregulated at all dpa, as was decorin, which interacts with collagen1 fibrils and may affect the rate of their formation. However, matrilin (MATN) 4, a major component of cartilage matrix, was upregulated at 1 and 4 dpa, then downregulated at 7 dpa. FBN1, a large glycoprotein that associates with elastin to provide force-bearing support in the ECM, was upregulated at 1 and 7 dpa, with no change at 4 dpa. MATN 2, a von Willebrand family member involved in matrix assembly, was upregulated at 1 and 4 dpa, then returned to control level at 7 dpa. FGB, FGG, and fibronectin 1 (FN1) form part of the provisional wound matrix (clot) and were upregulated at all dpa, whereas another provisional matrix protein, tenascin, was downregulated at 1 dpa, showed no change at 4 dpa, and was upregulated at 7 dpa. Periostin, an osteoblast specific factor, was downregulated at 1 and 4 dpa, but upregulated at 7 dpa. EHD4, an endosomal transport protein that promotes assembly and stabilization of collagen 6 filaments, showed no change at 1 dpa and was downregulated at 4 and 7 dpa. Tubulointerstitial nephritis antigen (TINAG), a basement membrane glycoprotein that mediates adhesion of proximal tubule epithelial cells via cell surface integrins, was downregulated on all dpa.
Eight proteins directly or indirectly involved in oxidative phosphorylation were detected. ATP5B, COX-Va, ECHS1, GLUD1 and CS function in the citric acid cycle; most were downregulated at all or two of three dpa. The only mitochondrial metabolic protein that was upregulated at all dpa was SLC25A4, an adenine nucleotide translocator that catalyzes the exchange of adenosine di- and triphosphate (ADP and ATP) across the inner mitochondrial membrane, but a second translocator, SLC25A13, was downregulated at all dpa. Eight proteins involved in the glycolytic pathway were detected, most of which were downregulated at all or two of three dpa. Two proteins, PGM1 and PYGM, are involved in glycogen metabolism; both were downregulated at all dpa.
In all, 15 other metabolic proteins were detected. Most were downregulated at 1 and 4 dpa, with the U/D ratio rising to 1.00 at 7 dpa. Three exceptions were DAGLB, which catalyzes DAG to the endocannabinoid 2-arachidonoyl glycerol (2-AG), DHRS4, which is involved in retinoid metabolism, and PAPPA2 a matrix metalloproteinase that cleaves IGFBP-5. All were upregulated on all dpa.
Seven proteins associated with the post amputation inflammatory response were antioxidants or antipathogens, proinflammatory enzymes, or detoxicants. The antioxidants PXDN and PRDX1 were upregulated on all dpa, while antioxidant TLR6 was upregulated at 1 and 4 dpa. OAS2 and GSTP1, which activate responses to pathogens, were upregulated at 4 and 7 dpa. The proinflammatory enzyme AOX1, by contrast, was downregulated at 1 and 4 dpa. CYP2F1, which plays a role in detoxification, was downregulated on all dpa.
A total of 13 apoptotic pathway-related proteins were detected. Six of these are involved in proapoptotic pathways, and all but one was downregulated on all or two of three dpa. The four downregulated proapoptotic proteins were MICB, a stress induced self-antigen that leads to cell lysis by T cells, VDAC1, a mitochondrial ion channel that promotes apoptosis when open, FASTKD5, which initiates caspase activity, and AK2, which is located in the mitochondrial intermembrane space. Exceptions were microtubule associated serine/threonine kinase 3 (MAST3), which was upregulated at 1 and 4 dpa, and ABTB1, which was upregulated at 4 and 7 dpa. ABTB1 mediates the phosphatase and tensin homolog (PTEN) growth-suppressive signaling pathway. Both negatively regulate the Akt cell survival pathway. Of the seven antiapoptotic proteins, three were downregulated at all or two of three dpa (AKT1S1, BIRC6, and PDCD6IP). Antiapoptotic proteins upregulated at two of three dpa were NEK11 (genotoxic stress reponse), tumor necrosis factor receptor-associated factor 1 (TRAF1; mediates antiapoptotic signals from TNF receptors), and PAIRBP1 (mediates the antiapoptotic action of progesterone in mammalian cells). Interleukin 7 receptor (IL7R), which blocks apoptosis during the differentiation and activation of T lymphocytes, was downregulated at 1 dpa and upregulated at 7 dpa.
A total of 15 proteins that promote or stabilize protein folding in the ER were detected. Four were isomerases. FKBP10 and P4HB were downregulated at all dpa and protein disulfide isomerase A3 (PDIA3) at 1 and 4 dpa. PPIA was upregulated at all dpa and PDIA6 was upregulated at 4 and 7 dpa. A total of 10 proteins were members of chaperone families that accelerate protein folding in the ER. Two of these were upregulated at all dpa (heat shock protein (HSP)B3, TOR1A), three were upregulated at 4 and 7 dpa (HSP90B1, HSP90AB2P, CCT2), one was upregulated at 1 dpa and downregulated at 4 and 7 dpa (HSP27), and two were downregulated at 1 and 4 dpa, but upregulated at 7 dpa (PCMT1, HSP90AA1). Two other chaperones (SSR1 and HSP90AA1) were downregulated at 1 dpa and upregulated at 7 dpa.
Misfolded or damaged proteins that cannot be salvaged are polyubiquinated in the ER, transferred to the Golgi, and then to a cytosolic complex of proteins called the 26S proteasome, where they are degraded . In our samples, we detected seven proteins of the proteasome pathway. HACE1 (a ubiquitin protein ligase) was upregulated at all dpa, and ubiquitin specific protease 3 (USP3), was upregulated at 1 and 7 dpa. Ubiquitin-like modifier activating enzyme 1 (UBA1) was upregulated at 1 dpa and downregulated at 4 and 7 dpa. We detected four proteins that are part of the proteasome itself. Three of the four were upregulated only at 7 dpa (PSMB8, PSMD 2,7), whereas PSMC4 was downregulated at 1 and 4 dpa before returning to control level at 7 dpa.
Cell debris produced by histolysis, necrosis or apoptosis, is degraded by cytosolic proteases and lysosomal enzymes, and removed by exocytotic pathways. EXOC7, a component of the exocyst, a protein complex essential for docking exocytotic vesicles to the plasma membrane, was upregulated at all three dpa, suggesting the removal of degraded material by this pathway. Other degradative enzymes were TMPRSS9 (a serine protease) and membrane metalloendopeptidase (MME), both of which degrade small peptides. The former was downregulated at all dpa (by nearly sevenfold at 7 days), while the latter was upregulated at 1 and 4 dpa.
NME1, a kinase involved in the synthesis of nucleoside triphosphates other than ATP was upregulated at all dpa. MMCM3 (required for DNA replication) was downregulated at all dpa and FUS (a heterogeneous nuclear protein that promotes annealing of complementary DNA strands) was downregulated at 1 and 4 dpa, but upregulated at 7 dpa. Five cell cycle progression proteins were identified. WDR36 and MARK4 were downregulated on all dpa, whereas ULA1 was upregulated on all dpa. LOH11CR2A, a von Willebrand family member, acts as a tumor suppressor and a negative regulator of the cell cycle. It was downregulated at 1 and 4 dpa, returning to control level at 7 dpa. PPP1C, a protein phosphatase required for chromatin condensation and maintenance of histone H3 phosphorylation during mouse oocyte meiosis , showed no change at 1 dpa, and then was downregulated at 4 and 7 dpa.
Several proteins implicated in mitotic spindle formation were detected. CROCC, which contributes to centrosome cohesion before mitosis and NDEL1, which anchors microtubules to the centrosome during interphase and localizes to mitotic spindles during mitosis were upregulated on all dpa. However, XMAP215 and Ras-related nuclear protein (RAN), which regulate microtubule assembly during the cell cycle, were downregulated on all dpa and on 1 and 4 dpa, respectively. RAN has other functions as well, including translocation of RNA and proteins through the nuclear pore complex, DNA synthesis, and cell cycle progression. Titin (TTN), which in skeletal muscle serves as an adhesion template for the assembly of contractile machinery, and may play a role in chromosome condensation and segregation in non-muscle cells, was upregulated at 1 and 4 dpa. EVI5, a centrosomal oncoprotein implicated in the prevention of premature entry of cells into mitosis, and in the completion of cytokinesis, was upregulated at 1 dpa nearly to the level attained by NOS1, but unlike NOS1 its level remained exceptionally high at 4 and 7 dpa as well.
Validation of proteomic methods
Antibodies to axolotl proteins are not available. Most commercially available antibodies are directed against human and mouse antigens. We therefore tested antibodies to a variety of mammalian proteins that were upregulated in our study on control and regenerating limb tissue. Antibodies to three of these, NOS1, FN, and α-actinin, reacted strongly enough on longitudinal sections of axolotl limb tissue for direct validation by immunohistochemistry. We therefore tested the expression of these proteins at 1 and 7 dpa relative to control tissue (Figure 4). NOS1 and fibronectin were upregulated at 1 and 7 dpa, whereas α-actinin was downregulated. Table 3 shows the densitometric quantification of these proteins in immunostained sections. The fold changes determined by liquid chromatography/mass spectrometry/mass spectrometry (LC-MS/MS) were congruent with the densitometric measurements, indicating that quantitative LC-MS/MS data accurately reflect the levels of specific proteins. Indirect validation from the literature provides further support for this conclusion. For example, the upregulation of retinoids and chaperones observed in regenerating urodele limbs [51–53] matches a similar upregulation of DHRS4 and multiple chaperones in our study, as does the downregulation of citric acid cycle enzymes observed by Schmidt .
Confidence in the methodology
We did not detect proteins such as Fgf-8, Hox a-d, sonic hedgehog, retinoic acid receptors, and matrix metalloproteinases whose transcripts are expressed during limb regeneration . This could be due to an inability of current LC-MS/MS technology to confidently detect low abundance proteins, most of which [except for matrix metalloproteinases (MMPs)] are strongly expressed only at stages of regeneration beyond accumulation blastema (see  for review). However, the advantages of the method far outweigh this limitation. Firstly, proteomic analysis has the general advantage over genomic analysis of detecting the end products of gene activity, thus ignoring transcripts that may never be translated. Secondly, the LC-MS/MS-based label-free protein quantification technology used here has proven itself a powerful tool to resolve and identify thousands of proteins from complex biological samples [55, 56]. It is a relative method that compares the expression level of the same protein under different conditions. The method is rapid and more sensitive than many other proteomic methods, and increases the protein dynamic range of threefold to fourfold compared to two-dimensional gel electrophoresis. During development of the method, chicken lysozyme was used as the quality assurance/quality control and the method has since been robustly tested on many different types of samples . Automation allows it to be applied for large-scale proteomic analysis; thus it has become a tool of choice for biomarker discovery [57, 58]. The inclusion of statistics in both experimental design and data analysis allows for the detection of small but significant changes not offered by other methods. We are thus confident in the qualitative and quantitative data produced in our study.
Significance of results
Signaling and Ca2+binding and translocation
Myoinositol is a precursor to PIP2, which is cleaved into IP3 and DAG. IP3 stimulates a rise in cytosolic Ca2+ that causes protein kinase C to translocate to the plasma membrane, where it is activated by DAG and regulates transcription . Our data support the idea that an increase in myoinositol after amputation initiates signals that result in a major increase in cytosolic Ca2+ by influx from extracellular sources or release from ER/SR stores. First, we found that ISYNA1, a key enzyme in the synthesis of myoinositol, is strongly upregulated. Second, we saw a general downregulation of proteins involved in Ca2+ homeostasis, which would lead to a rise in cytosolic Ca2+ that in turn would activate or suppress many different signaling pathways. One such downregulated protein was CAMK2D, which has also been implicated in the activation of enzymes such as NOS1 , regeneration of muscle fibers , and tissue repair . Our data are consonant with the results of other studies indicating that inositol phosphates are generated from PIP2 within 30 s after amputation of the newt limb and that inhibiting their formation by beryllium prevents blastema formation [62, 63]. They are also in harmony with studies showing that (1) intracellular Ca2+ release in response to mitogenic signals is essential for mitosis in the newt limb blastema, [64–66], (2) protein kinase C (PKC) activity rises to a plateau at accumulation blastema to medium bud , (3) planarian regeneration is dependent on Ca2+ , and (4) higher levels of several S100 family Ca2+-binding proteins are observed in the regenerating ear tissue of MRL/MpJ-Fas mice versus non-regenerating ear tissue of C57BL/6J mice, as determined by laser capture proteomics [69, 70].
In addition to Ca2+, the translocation of other ions is essential for blastema formation in amputated amphibian limbs and tails. Ionic currents leave the newt limb immediately upon amputation, driven by Na+ influx . Proton efflux across the wound epidermis of the amputated Xenopus tadpole tail is driven by a vacuolar ATPase pump . Vacuolar ATPases are expressed in the intracellular membranes (for example, lysosomes) of all eukaryotic cells , where they pump H+ ions inward to maintain an acidic pH. The tadpole tail pump, however, is a plasma membrane v-ATPase . Drug-induced inhibition of either Na+ or H+ movements results in failure of blastema formation [72, 74]. A v-ATPase did not appear in our priority 1 or 2 sets of proteins, but was present in the priority 4 set. Furthermore, a protein subunit of a v-ATPase was detected in the stage 53 hind limb bud of Xenopus at 3 dpa, using methods identical to ours , and a gene encoding a v-ATPase was the most abundant clone in a suppressive subtraction cDNA library made from 4 dpa axolotl regenerating limb tissue . Whether these are the same v-ATPases as the plasma v-ATPase of Adams et al.  is not known.
The annexins are phospholipid-binding signaling proteins that have been implicated in a variety of biological processes. Annexin 1 has been postulated to reduce inflammation in regenerating fish [76, 77] appendages and in stage 53 regeneration-competent Xenopus laevis limb buds . However, annexin 1 was upregulated only at 7 dpa in our samples. This expression pattern might reflect differences in the onset and/or persistence of the inflammatory phase of amputated axolotl limbs and Xenopus tadpole limb buds, differences in the immune systems of these species , or annexin 1 might have some other function in the accumulation blastema. Annexin 2 was upregulated at 1 and 4 dpa, and may be important for histolysis, since it has been shown to promote osteoclast formation and bone resorption . This function correlates with the destruction of the periosteal bone shell by osteoclasts during blastema formation. Annexins 4 and 6 also were upregulated only at 7 dpa. These two proteins promote exocytosis in epithelial cells, consistent with the phagocytosis and elimination of debris by wound epithelial cells observed during early blastema formation .
NOS1 was the most strongly upregulated protein (4.93) at 1 dpa and was still upregulated relative to control at 4 and 7 dpa, although the fold change declined on each of these days. NOS1 catalyzes the synthesis of NO, which has a wide variety of signaling functions . NO displays many properties of a neurotransmitter in the nervous system. It is produced by macrophages and neutrophils as a bactericidal agent, and has a role in activating proteases that are known to be important effectors of histolysis in regenerating limbs [82–85]. Immunostaining showed NOS1 to be expressed only in the epidermis over the period of blastema formation (Figure 4). This localization suggests that NO diffusing inward from the epidermis may be important to signaling pathways that regulate blastema formation. Grow et al.  found that the NOS1 gene was strongly upregulated in amputated stage 53 regeneration-competent Xenopus limb buds versus regeneration-deficient stage 57 limbs, suggesting that loss of NOS1 production is associated with loss of regenerative competence in Xenopus limb buds.
In addition to NOS1, other important signaling molecules and receptors, such as the nicotinic acid receptor, the insulin receptor, the ephrin receptor, tyrosine kinase 2, and GNB2L1, an anchor of PKC to the cytoskeleton, were upregulated on all or two of three dpa. Several Rab family GTPases and their activators and exchangers were differentially regulated. This family plays a critical role in regulating vesicle trafficking of proteins, including recycling of receptors, from one membrane compartment to another .
Five proteins involved in canonical or non-canonical Wnt signaling were detected. Wnt8 is considered a ligand for the canonical pathway, whereas other Wnt ligands seem to signal through the non-canonical pathway. These include Wnt3a and 4 in wound repair  and bone formation [88, 89], and Wnt5a in Xenopus embryo convergent extension movements , and mouse embryo midgut elongation . In our study, Wnt8 and APC were upregulated at 4 and 7 dpa. These are components of the canonical pathway that stabilizes β-catenin. Inversin switches the canonical pathway to the non-canonical pathway, by targeting the Disheveled protein for degradation by the proteasome or by the activation of the c-jun N-terminal kinase (JNK) pathway by DVL2 and axin . Our results are consistent with the finding that Wnt genes for both pathways are expressed in the regenerating axolotl limb . However, the fact that the DVL-binding protein CCDC88c, a negative regulator of the canonical pathway is upregulated on all dpa, and DIXDC1, a positive effector of the canonical pathway is downregulated on all dpa while inversin is upregulated over twofold by 7 dpa would suggest that regeneration in the axolotl limb might be promoted by the non-canonical Wnt pathway. By contrast, the canonical pathway (via Wnt8) was found to promote zebrafish fin regeneration whereas the non-canonical pathway inhibited it . The canonical Wnt pathway has also been implicated in deer antler regeneration  and Xenopus tadpole tail regeneration . Further studies will be required to understand the details of how Wnt signaling pathways regulate appendage regeneration in different species.
Transcription and translation
Previous studies of RNA and protein synthesis have shown that both increase during blastema formation, but do not reach maximum until differentiation of the new limb elements is initiated [36, 37, 39, 41, 97, 98]. The U/D ratios for our data suggest that proteins involved in the transcriptional and translational machinery are generally upregulated, insuring that this machinery is available for whatever protein synthesis is required. However, the mRNA processing proteins appeared to be an exception, since their U/D ratio was quite low at 1 day, and did not rise above 1.0 until 7 dpa. This might mean that mRNA processing is a critical level of control for protein synthesis in general during blastema formation.
In addition, there were quantitative changes in chromatin proteins that suggest transcriptional changes by chromatin modification. The transcription factor hairless was upregulated at 1 and 4 dpa, possibly functioning to recruit histone deacetylases, and the histone lysine demethylase JMJD1B was downregulated sixfold at 7 dpa. Both of these patterns suggest transcriptional repression [99, 100].
Cytoskeleton and ECM
The downregulation of sarcomeric proteins on all or two of three dpa, many over twofold, is consistent with cellularization of myofibers into mononucleate cells that undergo dedifferentiation [11, 14, 63, 97]. The gradual rise in U/D ratio for motility, shape and structural integrity proteins at 4 and 7 dpa and the high U/D ratio for adhesion proteins such as SCARF2 and ST3GAL5, particularly at 1 and 4 dpa, is consistent with the migration of epidermal cells to close the wound, and the migration of dedifferentiating cells to accumulate under the wound epidermis. CDH5, a cadherin that mediates junctional adhesion of endothelial cells was upregulated at all dpa, perhaps reflecting the sealing of blood vessels and the initiation of new vessel formation.
The major vault protein (MVP) is the main component of vaults, large ribonucleoprotein particles that have been implicated in regulating cytoskeletal-associated kinase signaling [101–103]. The gene for this protein was upregulated in the established blastema of the regenerating zebrafish fin . We found that the MVP was downregulated in amputated axolotl limbs at 1 and 4 dpa, but returned to control level at 7 dpa after an accumulation blastema was established. This fact, and the downregulation of another cytoskeleton-associated kinase, PDLIM1, may suggest less intracellular signaling by cytoskeletal-associated kinases during blastema formation.
With regard to ECM proteins, the upregulation of fibrinogen reflects formation of the fibrin clot. The upregulation of fibronectin and collagen 1, the downregulation of collagens 2 and 4, and the downregulation of EHD4, an endosomal trafficking regulatory protein  present in the matrix of differentiating cartilage and fibroblastic connective tissue during rat limb development , is consistent with other observations indicating that the differentiated tissue matrix is replaced by an ECM that is more similar to the limb bud matrix, and more favorable to the migration of dedifferentiated cells to form the blastema under the wound epidermis .
Metabolism and cell protection mechanisms
Amputation results in tremendous systemic and cellular stress. We found that DAGLB, which catalyzes the conversion of DAG to 2-AG, was highly upregulated on all dpa. 2-AG is required for axonal growth during development, and thus may play a role in nerve regeneration into the blastema, but it is also the most abundant endocannabinoid in adult tissues, suggesting its involvement in pain control during blastema formation. Our data are thus consistent with previous studies indicating that endorphins are upregulated after newt limb amputation [108, 109]. The evolution of such painkilling mechanisms in urodele salamanders can be interpreted in terms of an adaptive response to the frequent cannibalization of limbs in the wild that occurs under conditions of crowding or inadequate food.
A major result of cell stress is apoptosis. Our data suggest that stress caused by amputation activates mechanisms to protect cells from apoptosis in regenerating axolotl limbs. The blastema forms under largely avascular, and thus hypoxic conditions [14, 110] that could lead to apoptosis. Mammalian cells deal with hypoxia by upregulating hypoxia induced factor 1A (HIF1a), which regulates numerous downstream genes, including the PI3 kinase-dependent cell survival gene Akt and glycolytic enzymes to maintain ATP production [111–113]. Mammalian cells that fail to maintain ATP synthesis under hypoxic conditions are subject to apoptosis .
Naviaux et al.  compared metabolism in fibroblasts of the MRL/lpj mouse, which regenerates ear and heart tissue  versus the non-regenerating B6 mouse. They found that MRL fibroblasts exhibited the Warburg effect , a major feature of embryonic cell metabolism shared by cancer cells and cells involved in adult wound healing [117, 118]. The Warburg effect is the increased reliance on glycolytic metabolism while maintaining normal O2 consumption. In spite of reduced energy production by oxidative phosphorylation, the number of mitochondria was higher in MRL than B6 cells, suggesting an under utilized functional reserve capacity . Gorsic et al.  detected significant upregulation of the genes for cytochromes b and c and intense antibody staining to these cytochromes in the epidermis and underlying tissue of 4 dpa regenerating axolotl limbs, suggesting a similarity between axolotl and MRL cells in terms of mitochondrial enhancement.
Our data indicated that citric acid cycle and electron transport enzymes are downregulated on all or two of three dpa, consistent with previous studies showing a marked decrease in O2 usage during blastema formation in regenerating urodele limbs  and the histochemical absence of citric acid cycle enzymes [54, 120]. Schmidt  proposed that the early blastema relies on anaerobic glycolysis or alternate pathways such as the pentose phosphate shunt and lipid metabolism to maintain ATP production. However, in our samples most of the glycolytic enzymes detected were downregulated throughout blastema formation. NO inhibits glycolysis and electron transport in skeletal muscle . Thus the upregulation of NOS1, particularly at 1 dpa, might play a significant role in metabolic depression. A decrease in muscle metabolism during myofiber fragmentation and cellularization would account for much of this depression. Enough ATP production would remain, however, to synthesize the proteins necessary for epidermal wound healing, histolysis, and dedifferentiation. Lastly, one of the more strongly upregulated proteins on all dpa was DHRS4, which is involved in the reversible reduction of all-trans and 9-cis retinal. This upregulation is consistent with the important roles retinoids play, not only in metabolism, but also in the patterning of the blastema [51, 122]. The role of specific metabolic changes in blastema formation merits revisitation.
Our histological observations indicated little cell apoptosis on 4 and 7 dpa, consistent with the results of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays [123, 124]. We propose that apoptosis is minimized by reducing metabolism and engaging protective mechanisms that include the upregulation of antimicrobial and antioxidant proteins, the differential regulation of proapoptotic and antiapoptotic proteins, and the unfolded protein response (UPR). The UPR is a response to cell stress caused by the accumulation of unfolded proteins within the ER/SR due to loss of Ca2+ homeostasis, inadequate disulfide bond formation of nascent proteins by isomerases, or deficient protein glycosylation [49, 125, 126]. The UPR counters this stress in several ways: reducing the amount of protein translocated into the lumen, increasing protein degradation by proteasomes and exocytotic mechanisms, and increasing the capacity to accelerate protein folding in the ER by upregulating isomerases and chaperones. Failure to refold misfolded proteins or remove them from the ER results in apoptosis.
Our evidence for this idea is as follows. Firstly, antimicrobial and antioxidant proteins were consistently upregulated, and proinflammatory enzymes downregulated on most dpa. Secondly, four of five proapototic proteins were downregulated on all or two of three dpa. Conversely, four of seven antiapoptotic proteins were upregulated in the same pattern, although the AKTS1 protein, a substrate for the Akt survival enzyme, was downregulated on all dpa. Thirdly, the upregulation of two isomerases and several chaperones on all or two of three dpa suggests that the regenerating limb mounts an UPR. The upregulation of chaperone genes has been reported in other studies of regenerating newt and axolotl limbs [35, 52, 53], Xenopus stage 52 hindlimbs , and zebrafish fins [76, 104]. Interestingly, in Xenopus limb buds rendered regeneration deficient by heat shock induced expression of transgenic noggin, chaperone gene expression is not maintained as it is in wild-type buds . Gorsic et al.  reported the upregulation of two genes associated with combating cell stress in regenerating axolotl limbs at 4 dpa. These were Sara1b, a Ras-related gene whose product is involved in protein transport from the ER to the Golgi, and Hmox-1, which increases tolerance to hypoxia and protects against apoptosis . This enzyme is also upregulated during liver regeneration .
Dedifferentiation occurs in conjunction with the liberation of cells from their tissue matrix by protease-induced histolysis. Dedifferentiated cells express a number of genes associated with the dedifferentiated state, such as msx1 , Nrad , rfrng and notch . Nuclear transplantation studies  and ectopic grafting experiments  have shown that blastema cells are not reprogrammed to pluripotency. However, three of the four transcription factor genes (Klf4, Sox2, c-myc) used to reprogram mammalian adult somatic cells to pluripotency [48, 134] are upregulated during blastema formation in regenerating newt limbs, and also during lens regeneration . Beyond this, little is known about the molecular mechanism of dedifferentiation in the regenerating urodele limb. Interestingly, we found that LIN28, a fourth transcription factor used to reprogram mammalian somatic cells to pluripotency , was upregulated on all dpa. Thus it is possible that LIN28 might play a role in the transcriptional regulation of nuclear reprogramming during limb cell dedifferentiation. The molecular characterization of blastema cell surface antigens and study of the regulation of dedifferentiation by transcription factors, microRNAs, polycomb proteins and chromatin-modifying enzymes will be crucial for understanding the mechanism of dedifferentiation in regenerating amphibian limbs.
In a recent meeting review, Tanaka and Galliot  described data presented by Andras Simon indicating that activation of apoptotic pathways in cultured newt myotubes resulted in their cellularization, suggesting that these pathways might play a role in dedifferentiation. Our data suggest both positive and negative regulation of apoptotic pathway proteins. We suggest that some apoptotic pathways involved in eliminating internal structure (dedifferentiation) are selectively activated, while others that would destroy nuclei and plasma membranes are selectively downregulated. Evidence from other systems is consistent with this idea. Firstly, treatment of cultured insulin-producing INS-1E cells with the reversible ER stress inducer cyclopiazonic acid (CPA) upregulated genes related to ER stress while simultaneously downregulating genes related to differentiated β-cell functions . Secondly, NO signaling inhibits apoptosis and induces dedifferentiation of chondrocytes in vitro via p38 kinase and calveolin 1 [138, 139]. The UPR is induced in mice transgenic for a mutation that leads to accumulation of misfolded collagen 10 α1 (X) chains in the hypertrophic chondrocytes of developing endochondral bones . However, instead of undergoing apoptosis, the chondrocytes undergo dedifferentiation, with re-expression of genes characteristic of a prehypertrophic state and re-entry into the cell cycle. Thirdly, paraquat treatment causes oxidative stress that induces the apoptosis of retinal photoreceptors and amacrine neurons in vitro, but promotes dedifferentiation of Muller glial cells, which have been proposed as a source of retinal stem cells . Furthermore, coculturing retinal neurons with glial cells prevented paraquat-induced apoptosis. These results suggest that oxidative stress may activate Muller glia to both protect and replenish retinal neurons. Fourthly, newt and chick embryo retinal pigmented epithelial (RPE) cells can dedifferentiate and then become neurons or lens cells [142–144]. Dedifferentiation of chick embryo RPE cells is dependent on a rise in intracellular Ca2+  and neuronal Na+ and Ca2+ channels have been detected in cultured newt RPE cells . Lastly, cell stress induces dedifferentiation and an epithelial to mesenchymal (EMT)-like phenotype in cultured PC C13 thyroid cells . The relationship between apoptosis and dedifferentiation is thus another potentially exciting avenue of regeneration research.
Cell cycle proteins and blastema formation
In all, 14 proteins associated with the cell cycle were detected. Of these, EVI5, the ecotropic viral integration site 5, was of interest because it was the most strongly upregulated protein over all dpa. EVI5 is a centrosomal oncoprotein that has several forms that interact directly with several other proteins in the cell cycle  (Figure 5). The 110-kDa form of EVI5 accumulates in the nucleus during early G1. It prevents cells from prematurely entering mitosis by stabilizing Emi1, a protein that accumulates in late G1 and inhibits cyclin A degradation by the anaphase-promoting complex/cyclosome (APC/C), allowing the cells to traverse S . Emi1 and EVI5 are then targeted for ubiquitin-driven degradation after being phosphorylated by Polo-like kinase 1 (PLK1), allowing the cell to enter mitosis. The 110-kDa form of EVI5 may be degraded into 90-kDa and 20-kDa forms that at anaphase become associated with the chromosomal passenger complex (CPC) consisting of aurora B kinase, inner centromere proteins (INCENP), and survivin . At late telophase and cytokinesis, EVI5 dissociates from the CPC and localizes in the region between the two daughter cells. Knockdown of EVI5 inhibits cytokinesis and results in the formation of binucleate cells . EVI5 also renders the vesicle trafficking protein Rab 11 inactive, which would help restrain cells from entering mitosis by inhibiting the vesicular recycling of growth factor receptors that would otherwise promote the transduction of mitotic signals [150, 151].
An interesting role for EVI5 in blastema formation can be postulated based on its functions in the mammalian cell cycle. Histological [17–19, 152, 153], electron microscopic  and genetic marking  studies indicate that cells located within the histolytic region of amputated urodele limbs begin to dedifferentiate within 2 dpa. Chalkley [17, 18] showed that cell number during histolysis in this region is highest just proximal to the amputation plane. However, the mitotic index during histolysis is very low (0.1% to 0.5%) [17, 20, 21]. Coincident with the appearance of the blastema, the high point in cell number moves distal to the amputation plane, indicating that the blastema forms primarily by the distal migration and accumulation of dedifferentiated cells under the wound epidermis . The mitotic index of blastema cells rises significantly only after the accumulation blastema has formed.
The cycle time of axolotl blastema cells at stages later than accumulation blastema is 40 h, with 39 h (approximately 1.5 days) spent in G1/S/G2 . The high level of EVI5 during blastema formation suggests that it extends (by stabilizing Emi1) the premitotic portion of the cell cycle beyond 39 h for whatever period of time is required to form an accumulation blastema (in our case, 7 days). EVI5 would then be cleaved, the cells would traverse M and continue to cycle on the neural and epidermal-dependent 40 h time scale. This hypothesis makes two predictions. Firstly, only the 110-kDa form of EVI5 would be detected in blastema cells during formation of the accumulation blastema, but that the 90-kDa and 20-kDa forms would also be detected, in association with CPC proteins, as normal cycling began. Secondly, denervation or blocking contact of blastema cells with the wound epidermis, either of which inhibits blastema cell mitosis at any stage of regeneration , would cause cell cycle arrest, most likely in S or G2 phases, due to maintenance of high levels of EVI5. The role of neural and epidermal factors in mitosis, such as nAG  and Fgf-8  would then be to signal for the cleavage of EVI5.
Interestingly, the CPC protein aurora B kinase appears to dissociate HP1 proteins from methylated histone H3 at the onset of mitosis [156–158], and is required for chromatin remodeling during postmitotic differentiation of mesenchymal stem cells and B cells . Aurora B kinase maintains C2C12 cells in a differentiated state by phosphorylating serine 10 of histone 3 . The small synthetic molecules reversine and hesparadin inhibit this phosphorylation, silencing muscle regulatory factor genes and inducing the inhibitor of differentiation gene, an induction that involves decreasing the methylation of histone H3 lysine 9 and increasing overall H3 acetylation. Treated C2C12 cells are then able to differentiate into adipocytes and osteoblasts .
The role of EVI5 and CPC proteins in the cell cycle and their relation to chromatin structure, dedifferentiation, and differentiation during regeneration will be an interesting avenue to explore.
Figure 6 depicts a model of regeneration based on integrating our findings with those of others. We recognize that many of the proteins detected in this analysis have multiple functions, and that their roles can therefore be subject to more than one interpretation. Thus we are pursuing a systems biology approach to use the high-abundance proteins revealed in our analyses as bait to retrieve associated low-abundance proteins from the literature and construct all possible protein networks and pathways involved in successful limb regeneration. Which of these pathways are correct, and their precise roles, can then be tested by loss and gain of function experiments.
We have also analyzed the fold changes of proteins during pseudoblastema formation in the amputated Xenopus froglet hindlimb, which regenerates only a muscle-less spike of cartilage . The findings of this analysis will be compared to those reported here on the axolotl in order to gain insights into why the anuran limb bud loses the capacity for regeneration as it differentiates. This information will be useful in devising chemical induction strategies to reprogram mammalian somatic cells or activate resident stem cells directly at the site of injury to regenerate damaged tissues and appendages .
Animal surgery and tissue collection
All surgical procedures and animal care were carried out according to the Association for Assessment and Accreditation of Laboratory Animal Care (AALAC) standards followed at Indiana University-Purdue University Indianapolis (IUPUI), Purdue, IN, USA. Ambystoma mexicanum (axolotls) were obtained either by in-house breeding, or from the axolotl colony, University of Kentucky, Lexington, KY, USA. Animals 8 to 11 cm in length were anaesthetized in 0.02% to 0.05% MS-222 (Argent Chemical Laboratories, Redmond, WA, USA) and hind limbs were amputated bilaterally at mid-tibia/fibula. The tissue removed distal to the amputation site (what would be regenerated) served as the 0-day control. The regenerating tissue, along with a sliver (approximately 1 mm) of stump tissue, was collected at 1 day (epidermal wound healing), 4 days (histolysis and dedifferentiation) and 7 days (accumulation blastema) post amputation (dpa). The tissues were rinsed in sterile phosphate buffered saline (PBS) and flash frozen for proteomic analysis, which was conducted by Monarch Life Sciences (Indianapolis, IN, USA).
Histology, immunostaining and image analysis
For histology, control and regenerating limb tissues at 1, 4, and 7 dpa were fixed in Bouin's solution for 48 h. Fixed tissues were then washed in 50% alcohol to remove the picric acid and stored in 70% alcohol. The tissues were dehydrated in a graded series of alcohols to 100%, followed by two changes of xylene for 45 min to 1 h each, after which they were infiltrated overnight with Pararaplast (Fisher Healthcare, A Fisher Scientific Company, Houston, TX, USA). The tissues were then embedded in fresh Paraplast and sectioned at 10 μm. Sections were stained with Weigert's iron hematoxylin and light green SF yellow and photographed at 10 × magnification on a Nikon Eclipse E800 microscope (Nikon Instruments Inc, Melvlle, NY, USA).
For immunostaining, control and regenerating limb tissues were collected at 1 and 7 dpa and fixed overnight in 2% paraformaldehyde in 0.8 × PBS. The samples were then rinsed with 1.0 × PBS and decalcified for 30 min using immunoclear decalcifying agent (Calci-Clear Rapid, National Diagnostics, Atlanta, GA, USA). After decalcification, the samples were cryoprotected by sequential overnight incubation in 10%, 20% and 30% sucrose in 1 × PBS, then embedded in a 50:50 mixture of 30% sucrose and Neg 50 frozen section medium (Thermo-Fisher Scientific, Waltham, MA, USA). Sections were cut at 10 μm on a Leica CM1900 cryostat (Leica, Wetzlar, Germany) and incubated in 1 × PBS to remove excess embedding medium, then blocked for 30 min in a solution of 0.01% Tween-20 and 5% milk in tris(hydroxymethyl)aminomethane (Tris)-buffered saline. Sections were then incubated over night with polyclonal anti-rabbit NOS1 (Biomol International LP, Plymouth Meeting, PA, USA) at 1:70 dilution, polyclonal anti-human fibronectin (Sigma, St Louis, MO, USA) at 1:400 dilution or monoclonal anti-α-actinin (Sigma) at 1:200 dilution, washed with blocking solution, incubated in the appropriate secondary antibody (goat anti-mouse AF488 or goat anti-rabbit AF568, Invitrogen, Carlsbad, CA, USA) for 40 min, washed with 1 × PBS and mounted with Vectashield mounting medium containing 4',6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA).
Immunostained sections were observed using the 20 × objective lens on a Zeiss Axiovert 200 M microscope (Carl Zeiss Microimaging, Thornwood, NY, USA) equipped with an apotome for optical sectioning, and images were captured with an Axiocam MRM high-resolution camera. Sections were obtained from two hindlimbs of three animals for each time point. Six images were collected for each section, from regions located at the tip of the amputated limb to just proximal to the plane of amputation for 1 and 7 dpa samples and across the putative amputation plane in control sections. Mean pixel intensities were calculated for each image by sampling 20 randomly distributed regions of each image using the measurement package of the Axiovision software. Regions of sections containing bone were omitted from analysis, as some bone tissue displayed autofluorescence. Statistical comparisons were performed using analysis of variance (ANOVA). A P value < 0.05 was considered statistically significant.
A total of five pools of tissue each from control, 1 dpa, 4 dpa and 7 dpa limbs were collected. Each pool contained six tissues (from two hindlimbs of three animals). The samples were processed as described previously . Briefly, flash-frozen tissues were homogenized in lysis buffer containing 8 M urea and 10 mM dithiothreitol (DTT). The resulting cell lysates were denatured by urea, reduced by triethylphosphine, alkylated by iododethanol and digested by trypsin. The BCA Protein Assay (Bio-Rad, Hercules, CA, USA) was used to determine the peptide concentration in each pool.
Tryptic digested peptides were analyzed as previously described . Samples were run on a Surveyor high performance liquid chromatography (HPLC) system (Thermo-Fisher Scientific) with a zorbax 300SB-C18 reverse column (1 mm × 5 cm). Each peptide pool (20 μg) was injected twice onto the column in a random order. All injections were performed using the identical equipment configuration. Peptides were eluted with a gradient from 5% to 45% acetonitrile developed over 120 min at a flow rate of 50 μl/min, and effluent was electrosprayed into the LTQ mass spectrometer (Thermo-Fisher Scientific). Data were collected in the 'TriplePlay' mode (MS scan, zoom scan, and MS/MS scan). The resulting data were filtered (to increase the signal to noise ratio) and analyzed by a proprietary algorithm developed by Higgs et al. .
Using SEQUEST (Thermo Fisher Scentific, Waltham, MA, USA) and X! Tandem (an open source algorithm provided by The Global Proteome Machine Organization http://www.thegpm.org database search algorithms, database searches against non-redundant (NR) National Center for Biotechnology Information (NCBI) or International Protein Index (IPI) databases were performed for peptide sequence identification. A confidence score was assigned to each peptide by q value (false discovery rate) . The score was based on a random forest recursive partition supervised learning algorithm. The percentage ID confidence score was calibrated so that approximately X% of the peptides with percentage ID confidence >X% were correctly identified .
Proteins were classified according to identification quality (priority). This priority system is based on the quality of the amino acid sequence identification (peptide ID confidence) and whether one or more unique peptide sequences were identified (multiple sequences). The peptide id confidence assigned a protein into 'high' or 'moderate' categories based on the peptide with the highest peptide ID confidence (the best peptide). Proteins with 'best peptide' having a confidence between 90% to 100% were assigned to the 'high' category while proteins with best peptide having a confidence between 75% to 89% were assigned to the 'moderate' category. All peptides with confidence less than 75% were discarded. To increase the confidence in protein identification, the proteins were further classified based on the number of distinct amino acid sequences identified. A protein was classified as 'yes' if it had at least two distinct amino acid sequences with the required ID confidence; otherwise it was classified as 'no'. Thus, the proteins with 'high' peptide ID confidence and with more than one identified peptide sequence were termed priority 1. Proteins with 'high' peptide confidence but with only one identified peptide sequence were termed priority 2. Priority 3 and 4 proteins were those with 'moderate' peptide confidence with more than one and only one peptide sequence identified, respectively. Thus, priority 1 proteins had the highest likelihood of correct identification and priority 4 proteins the lowest likelihood of correct identification.
Protein quantification and statistical analysis
Protein quantification was carried out using non-gel based and label-free proprietary protein quantification technology described previously [57, 162]. All measurements on experimental samples reflect up or downregulation, or no change, relative to control samples. Every peptide quantified had an intensity measurement for every sample. This measurement is a relative quantity giving the area under the curve (AUC) from the extracted ion chromatogram (XIC) after background noise removal. The AUC was measured at the same retention time window (1 min) for each sample after the sample chromatograms had been aligned . The intensities were then transformed to the log base 2 scale (commonly used for genomic data), which served several purposes. First, relative changes in protein expression are best described by simple ratios. However ratios are difficult to model statistically, so log transformation converts ratios to fold differences. Second, the transformed data better approximate a normal distribution on a log scale , which is important because normality is an assumption of the ANOVA models used to analyze this data. Third, log base 2 is easy to understand because a twofold change (or doubling, or 100% increase) yielding an expression ratio of 2 is transformed to 1 (that is, a twofold change is a unit change on the log base 2 scale). After log transformation the data were then quantile normalized . This normalization removed trends introduced by sample handling, sample preparation, HPLC, mass spectrometry, and possible total protein differences.
If multiple peptides had the same protein identification, their quantile normalized log base 2 intensities were weight averaged proportionally to their relative peptide ID confidences. Then, the log base 2 protein intensities were fitted by a separate ANOVA statistical model for each protein. Finally, the inverse log base 2 of each sample mean was calculated to determine the fold change (FC) between samples. The maximum observed absolute FC was also given for each priority level. FC was computed as mean regeneration group/mean control group. A FC of 1 means no change.
The number of proteins with significant changes for each priority was calculated. The threshold for significance was set to control the false discovery rate (FDR) for each two-group comparison at 5% . The FDR was estimated by the q value, as stated previously. Thus protein fold changes with a q value less than or equal to 0.05 were declared to be significant, leaving 5% of the determined changes assumed to be false positives.
We calculated the median percentage coefficient of variance (%CV) for each priority group. Percentage CV values were derived from the standard deviation divided by the mean on a percentage scale. The percentage CV was calculated for replicate variation (technical variation) and the combined replicate plus sample variation.
In constructing biological process categories, only proteins having peptide confidence levels of 90% and above and with FDR < 0.05 were included. Many proteins were identified either by the same sequences or different sequences in priority 1 or 2 or both. To avoid redundancy, the fold changes of priority 1 were used if a protein was present in both the priorities, and average fold change was calculated if it belonged to same priority. If a protein had conflicting expression patterns (upregulated in one case, but downregulated in the other) then it was not considered.
Proteins not recognized by the algorithm were manually curated. NCBI blastp (basic local alignment search tool for proteins)  was used to match the sequences of hypothetical/novel/unknown/unnamed/Locus (LOC)/NIH Mammalian Gene Collection (MGC) proteins against the 'vertebrata' category in blast (taxid: 7742) to identify their closest neighbors. Only the proteins having 90% peptide ID confidence and above and with FDR < 0.05 were chosen. Accession numbers, gene names and names of the proteins were obtained from Uniprot  or NCBI  using the protein IDs obtained in the raw data. GeneCards  and Uniprot were used to determine their biological processes. The Human Protein Reference Database (HPRD)  was used to determine molecular function and primary cellular localization. The EVI5 network was generated using MetaCore analytical suite version 5.3 (GeneGo, St Joseph, MI, USA). Cluster 3.0  and Java Treeview software  available from Stanford University were used to generate the global intensity expression map.
All non-redundant peptides having a peptide ID confidence of 90% and above were compared against expressed sequence tag (EST) contigs from the Ambystoma ESTdb (SR Voss) using tBLASTn.
Goss RJ: Tissue differentiation in regenerating antlers. Biol Deer Production. 1985, 22: 229-238.
Goss RJ: Problems of antlerogesis. Clin Orthop Relat Res. 1970, 69: 227-238. 10.1097/00003086-197003000-00025.
Illingworth CM: Trapped fingers and amputated finger tips in children. J Pediatr Surg. 1974, 9: 853-858. 10.1016/S0022-3468(74)80220-4.
Borgens RB: Mice regrow the tips of their foretoes. Science. 1982, 217: 747-750. 10.1126/science.7100922.
Han M, Yang X, Farrington JE, Muneoka K: Digit regeneration is regulated by Msx1 and BMP4 in fetal mice. Development. 2003, 130: 5123-5132. 10.1242/dev.00710.
Goss RJ, Grimes LN: Tissue interactions in the regeneration of rabbit ear holes. Am Zool. 1975, 12: 151-157.
Heber-Katz E, Leferovich JM, Bedelbaeva K, Gourevitch D: Spallanzani's mouse: a model of restoration and regeneration. Curr Top Microbiol Immunol. 2004, 280: 165-189.
Tanaka EM: Regeneration: if they can do it, why can't we?. Cell. 2003, 113: 559-562. 10.1016/S0092-8674(03)00395-7.
Nye HL, Cameron JA, Chernoff EA, Stocum DL: Regeneration of the urodele limb: a review. Dev Dyn. 2003, 226: 280-294. 10.1002/dvdy.10236.
Stocum DL: Regenerative Biology and Medicine. 2006, San Diego, CA: Elsevier Inc
Brockes JP, Kumar A: Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat Rev Mol Cell Biol. 2002, 3: 566-574. 10.1038/nrm881.
Iten LE, Bryant SV: Forelimb regeneration from different levels of amputation in the newt Notophthalmus viridesces: length, rate and stages. W Roux Archiv. 1973, 173: 263-282. 10.1007/BF00575834.
Stocum DL: Stages of forelimb regeneration in Ambystoma maculatum. J Exp Zool. 1979, 209: 395-416. 10.1002/jez.1402090306.
Mescher AL: The cellular basis of limb regeneration in urodeles. Int J Dev Biol. 1996, 40: 785-795.
Cameron JA, Hilgers AR, Hinterberger TJ: Evidence that reserve cells are a source of regenerated adult newt muscle in vitro. Nature. 1986, 321: 607-610. 10.1038/321607a0.
Morrison JI, Loof S, He P, Simon A: Salamander limb regeneration involves the activation of a multipotent skeletal muscle satellite cell population. J Cell Biol. 2006, 172: 433-440. 10.1083/jcb.200509011.
Chalkley DT: A quantitative histological analysis of forelimb regeneration in Triturus viridescens. J Morphol. 1954, 94: 21-70. 10.1002/jmor.1050940103.
Chalkley DT: The cellular basis of limb regeneration. Regeneration in Vertebrates. Edited by: Thornton CS. 1956, Chicago, IL: University of Chicago Press, 34-56.
Hay ED, Fischman DA: Origin of the blastema in regenerating limbs of the newt Triturus viridescens. An autoradiographic study using tritiated thymidine to follow cell proliferation and migration. Dev Biol. 1961, 3: 26-59. 10.1016/0012-1606(61)90009-4.
Kelly DJ, Tassava RA: Cell division and ribonucleic acid synthesis during the initiation of limb regeneration in larval axolotls (Ambystoma mexicanum). J Exp Zool. 1973, 185: 45-54. 10.1002/jez.1401850105.
Loyd RM, Tassava RA: DNA synthesis and mitosis in adult newt limbs following amputation and insertion into the body cavity. J Exp Zool. 1980, 214: 61-69. 10.1002/jez.1402140109.
McCullough WD, Tassava RA: Determination of the blastema cell cycle in regenerating limbs of the larval axolotl, Ambystoma mexicanum. Ohio J Sci. 1976, 76: 63-65.
Tassava RA, Goldhamer DJ, Tomlinson BL: Cell cycle controls and the role of nerves and the regenerate epithelium in urodele forelimb regeneration: possible modifications of basic concepts. Biochem Cell Biol. 1987, 65: 739-749. 10.1139/o87-097.
Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP: Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science. 2007, 318: 772-777. 10.1126/science.1147710.
Steen TP: Stability of chondrocyte differentiation and contribution of muscle to cartilage during limb regeneration in the axolotl (Siredon mexicanum). J Exp Zool. 1968, 167: 49-78. 10.1002/jez.1401670105.
Cameron JA, Hinterberger TJ: Regional differences in the distribution of of myogenic and chondrogenic cells in axolotl limb blastemas. J Exp Zool. 1984, 232: 269-275. 10.1002/jez.1402320214.
Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH, Tanaka EM: Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature. 2009, 460: 60-65. 10.1038/nature08152.
Stocum DL, Zupanc GK: Stretching the limits: stem cells in regeneration science. Dev Dyn. 2008, 237: 3648-3671. 10.1002/dvdy.21774.
Geraudie J, Ferretti P: Gene expression during amphibian limb regeneration. Int Rev Cytol. 1998, 180: 1-50. full_text.
Carlson BM: Principles of Regenerative Biology. 2007, San Diego, CA: Academic Press
Grow M, Neff AW, Mescher AL, King MW: Global analysis of gene expression in Xenopus hindlimbs during stage-dependent complete and incomplete regeneration. Dev Dyn. 2006, 235: 2667-2685. 10.1002/dvdy.20897.
King MW, Nguyen T, Calley J, Harty MW, Muzinich MC, Mescher AL, Chalfant C, N'Cho M, McLeaster K, McEntire J, Stocum D, Smith RC, Neff AW: Identification of genes expressed during Xenopus laevis limb regeneration by using subtractive hybridization. Dev Dyn. 2003, 226: 398-409. 10.1002/dvdy.10250.
Pearl EJ, Barker D, Day RC, Beck CW: Identification of genes associated with regenerative success of Xenopus laevis hindlimbs. BMC Dev Biol. 2008, 8: 66-10.1186/1471-213X-8-66.
Gorsic M, Majdic G, Komel R: Identification of differentially expressed genes in 4-day axolotl limb blastema by suppression subtractive hybridization. J Physiol Biochem. 2008, 64: 37-50. 10.1007/BF03168233.
Monaghan JR, Epp LG, Putta S, Page RB, Walker JA, Beachy CK, Zhu W, Pao GM, Verma IM, Hunter T, Bryant SV, Gardiner DM, Harkins TT, Voss SR: Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration. BMC Biol. 2009, 7: 1-10.1186/1741-7007-7-1.
Bodemer CW: Distribution of ribonucleic acid in the urodele limb as determined by autoradiographic localization of uridine-H3. Anat Rec. 1962, 142: 147-148. 10.1002/ar.1091420207.
Bodemer CW, Everett NB: Localization of newly synthesized proteins in regenerating newt limbs as determined by radioautographic localization of injected methinine-S35. Dev Biol. 1959, 1: 327-342. 10.1016/0012-1606(59)90032-6.
Urbani E: Proteolytic enzymes in regeneration. Regeneration in Animals. Edited by: Kiortsis V, Trampusch HAL. 1965, Amsterdam, The Netherlands: North-Holland Publishing Co, 39-55.
Anton HJ: The origin of blastema cells and protein synthesis during forelimb regeneration in Triturus. Regeneration in Animals. Edited by: Kiortsis V, Trampusch HAL. 1965, Amsterdam: North-Holland Pub Co, 377-395.
Lebowitz P, Singer M: Neurotrophic control of protein synthesis in the regenerating limb of the newt, Triturus. Nature. 1970, 225: 824-827. 10.1038/225824a0.
Singer M, Ilan J: Nerve-dependent regulation of absolute rates of protein synthesis in newt limb regenerates. Measurement of methionine specific activity in peptidyl-tRNA of the growing polypeptide chain. Dev Biol. 1977, 57: 174-187. 10.1016/0012-1606(77)90363-3.
Dearlove GE, Stocum DL: Denervation-induced changes in soluble protein content during forelimb regeneration in the adult newt, Notophthalmus viridescens. J Exp Zool. 1974, 190: 317-328. 10.1002/jez.1401900308.
Slack JM: Protein synthesis during limb regeneration in the axolotl. J Embryol Exp Morphol. 1982, 70: 241-260.
Tsonis PA: A comparative two-dimensional gel protein database of the intact and regenerating newt limbs. Electrophoresis. 1993, 14: 148-156. 10.1002/elps.1150140123.
Tsonis PA, Mescher AL, Del Rio-Tsonis K: Protein synthesis in the newt regenerating limb. Comparative two-dimensional PAGE, computer analysis and protein sequencing. Biochem J. 1992, 281: 665-668.
Habermann B, Bebin AG, Herklotz S, Volkmer M, Eckelt K, Pehlke K, Epperlein HH, Schackert HK, Wiebe G, Tanaka EM: An Ambystoma mexicanum EST sequencing project: analysis of 17,352 expressed sequence tags from embryonic and regenerating blastema cDNA libraries. Genome Biol. 2004, 5: R67-10.1186/gb-2004-5-9-r67.
Putta S, Smith JJ, Walker JA, Rondet M, Weisrock DW, Monaghan J, Samuels AK, Kump K, King DC, Maness NJ, Habermann B, Tanaka E, Bryant SV, Gardiner DM, Parichy DM, Voss SR: From biomedicine to natural history research: EST resources for ambystomatid salamanders. BMC Genomics. 2004, 5: 54-10.1186/1471-2164-5-54.
Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007, 318: 1917-1920. 10.1126/science.1151526.
Lodish H, Berk A, Kaiser CA, Krieger M, Scott MP, Bretscher A, Ploegh H, Matsudaira P: Molecular Cell Biology. 2008, New York, USA: Freeman, 6
Swain JE, Ding J, Brautigan DL, Villa-Moruzzi E, Smith GD: Proper chromatin condensation and maintenance of histone H3 phosphorylation during mouse oocyte meiosis requires protein phosphatase activity. Biol Reprod. 2007, 76: 628-638. 10.1095/biolreprod.106.055798.
Maden M, Hind M: Retinoic acid, a regeneration-inducing molecule. Dev Dyn. 2003, 226: 237-244. 10.1002/dvdy.10222.
Carlone RL, Fraser GAD: An examination of heat-shock and trauma-induced proteins in the regenerating forelimb of the newt, Notophthalmus viridescens. Recent Trends in Regeneration Research. Edited by: Kiortsis V, Koussoulakos S, Wallace H. 1989, New York, USA: Plenum Press, 17-26.
Levesque M, Guimond JC, Pilote M, Leclerc S, Moldovan F, Roy S: Expression of heat-shock protein 70 during limb development and regeneration in the axolotl. Dev Dyn. 2005, 233: 1525-1534. 10.1002/dvdy.20458.
Schmidt AJ: Cellular Biology of Vertebrate Regeneration and Repair. 1968, Chicago, IL: The University of Chicago Press
Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B: Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem. 2007, 389: 1017-1031. 10.1007/s00216-007-1486-6.
Wang M, You J, Bemis KG, Tegeler TJ, Brown DP: Label-free mass spectrometry-based protein quantification technologies in proteomic analysis. Brief Funct Genomic Proteomic. 2008, 7: 329-339. 10.1093/bfgp/eln031.
Fitzpatrick DP, You JS, Bemis KG, Wery JP, Ludwig J, Wang M: Searching for potential biomarkers of cisplatin resistance in human ovarian cancer using a label-free LC/MS-based protein quantification method. Proteomics Clin Appl. 2007, 1: 246-263. 10.1002/prca.200600768.
Huang SK, Darfler MM, Nicholl MB, You J, Bemis KG, Tegeler TJ, Wang M, Wery JP, Chong KK, Nguyen L, Scolyer RA, Hoon DS: LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS ONE. 2009, 4: e4430-10.1371/journal.pone.0004430.
Nairn AC, Picciotto MR: Calcium/calmodulin-dependent protein kinases. Semin Cancer Biol. 1994, 5: 295-303.
Abraham ST, Shaw C: Increased expression of δCaMKII isoforms in skeletal muscle regeneration: implications in dystrophic muscle disease. J Cell Biochem. 2006, 97: 621-632. 10.1002/jcb.20669.
Levinson H, Moyer KE, Saggers GC, Ehrlich HP: Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction. Wound Repair Regen. 2004, 12: 505-511. 10.1111/j.1067-1927.2004.012502.x.
Tsonis PA, English D, Mescher AL: Increased content of inositol phosphates in amputated limbs of axolotl larvae, and the effect of beryllium. J Exp Zool. 1991, 259: 252-258. 10.1002/jez.1402590215.
Thornton CS: Amphibian limb regeneration. Advances in Morphogenesis 7. Edited by: Brachet L, King TJ. 1968, New York, USA: Academic Press, 205-244.
Globus M, Smith M, Vethamany-Globus S: Agonist-induced hydrolysis of inositol phospholipids in newt forelimb regeneration blastemas. Limb Development and Regeneration, Part B. Edited by: Fallon JF, Goetinck PF, Kelley RO, Stocum DL. 1993, New York, USA: Wiley-Liss, 695-703.
Globus M, Vethamany-Globus S, Kesik A: Control of blastema cell proliferation by possible interplay of calcium and cyclic nucleotides during newt limb regeneration. Differentiation. 1987, 35: 94-99. 10.1111/j.1432-0436.1987.tb00155.x.
Smith MJ, Globus M, Vethamany-Globus S: Nerve extracts and substance P activate the phosphatidylinositol signaling pathway and mitogenesis in newt forelimb regenerates. Dev Biol. 1995, 167: 239-251. 10.1006/dbio.1995.1020.
Oudkhir M, Martelly I, Castagna M, Moraczewski J, Boilly B: Protein kinase C activity during limb regeneration of amphibians. Recent Trends in Regeneration Research. Edited by: Kiortsis V, Koussoulakos S, Wallace H. 1989, New York, USA: Plenum Press, 69-79.
Martelly I, Franquinet R: Planarian regeneration as a model for cellular activation studies. Trends Biochem Sci. 1984, 8: 468-471. 10.1016/0968-0004(84)90310-4.
Caldwell RL, Caprioli RM: Tissue profiling by mass spectrometry: a review of methodology and applications. Mol Cell Proteomics. 2005, 4: 394-401. 10.1074/mcp.R500006-MCP200.
Caldwell RL, Opalenik SR, Davidson JM, Caprioli RM, Nanney LB: Tissue profiling MALDI mass spectrometry reveals prominent calcium-binding proteins in the proteome of regenerative MRL mouse wounds. Wound Repair Regen. 2008, 16: 442-449. 10.1111/j.1524-475X.2007.00351.x.
Borgens RB, Vanable JW, Jaffe LF: Bioelectricity and regeneration: large currents leave the stumps of regenerating newt limbs. Proc Natl Acad Sci USA. 1977, 74: 4528-4532. 10.1073/pnas.74.10.4528.
Adams DS, Masi A, Levin M: H+ pump-dependent changes in membrane voltage are an early mechanism necessary and sufficient to induce Xenopus tail regeneration. Development. 2007, 134: 1323-1335. 10.1242/dev.02812.
Stevens TH, Forgac M: Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol. 1997, 13: 779-808. 10.1146/annurev.cellbio.13.1.779.
Jenkins LS, Duerstock BS, Borgens RB: Reduction of the current of injury leaving the amputation inhibits limb regeneration in the red spotted newt. Dev Biol. 1996, 178: 251-262. 10.1006/dbio.1996.0216.
King MW, Neff AW, Mescher AL: Proteomics analysis of regenerating amphibian limbs: changes during the onset of regeneration. Int J Dev Biol. 2009, 53: 955-969. 10.1387/ijdb.082719mk.
Padhi BK, Joly L, Tellis P, Smith A, Nanjappa P, Chevrette M, Ekker M, Akimenko MA: Screen for genes differentially expressed during regeneration of the zebrafish caudal fin. Dev Dyn. 2004, 231: 527-541. 10.1002/dvdy.20153.
Nishidate M, Nakatani Y, Kudo A, Kawakami A: Identification of novel markers expressed during fin regeneration by microarray analysis in medaka fish. Dev Dyn. 2007, 236: 2685-2693. 10.1002/dvdy.21274.
Mescher AL, Neff AW: Regenerative capacity and the developing immune system. Adv Biochem Eng Biotechnol. 2005, 93: 39-66.
Menaa C, Devlin RD, Reddy SV, Gazitt Y, Choi SJ, Roodman GD: Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest. 1999, 103: 1605-1613. 10.1172/JCI6374.
Singer M, Salpeter MM: Regeneration in verebrates: the role of the wound epithelium in vertebrate regeneration. Growth in Living Systems. Edited by: Zarrow M. 1961, New York, USA: Basic Books
Lowenstein CJ, Snyder SH: Nitric oxide, a novel biologic messenger. Cell. 1992, 70: 705-707. 10.1016/0092-8674(92)90301-R.
Miyazaki K, Uchiyama K, Imokawa Y, Yoshizato K: Cloning and characterization of cDNAs for matrix metalloproteinases of regenerating newt limbs. Proc Natl Acad Sci USA. 1996, 93: 6819-6824. 10.1073/pnas.93.13.6819.
Ju BG, Kim WS: Upregulation of cathepsin D expression in the dedifferentiating salamander limb regenerates and enhancement of its expression by retinoic acid. Wound Repair Regen. 1998, 6: 349-357. 10.1046/j.1524-475X.1998.60410.x.
Yang EV, Gardiner DM, Carlson MR, Nugas CA, Bryant SV: Expression of Mmp-9 and related matrix metalloproteinase genes during axolotl limb regeneration. Dev Dyn. 1999, 216: 2-9. 10.1002/(SICI)1097-0177(199909)216:1<2::AID-DVDY2>3.0.CO;2-P.
Vinarsky V, Atkinson DL, Stevenson TJ, Keating MT, Odelberg SJ: Normal newt limb regeneration requires matrix metalloproteinase function. Dev Biol. 2005, 279: 86-98. 10.1016/j.ydbio.2004.12.003.
Takai Y, Sasaki T, Matozaki T: Small GTP-binding proteins. Physiol Rev. 2001, 81: 153-208.
Labus MB, Stirk CM, Thompson WD, Melvin WT: Expression of Wnt genes in early wound healing. Wound Repair Regen. 1998, 6: 58-64. 10.1046/j.1524-475X.1998.60109.x.
Tu X, Joeng KS, Nakayama KI, Nakayama K, Rajagopal J, Carroll TJ, McMahon AP, Long F: Noncanonical Wnt signaling through G protein-linked PKCδ activation promotes bone formation. Dev Cell. 2007, 12: 113-127. 10.1016/j.devcel.2006.11.003.
Bergenstock MK, Partridge NC: Parathyroid hormone stimulation of noncanonical Wnt signaling in bone. Ann N Y Acad Sci. 2007, 1116: 354-359. 10.1196/annals.1402.047.
Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, Takada S, Nishida E: JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 2002, 3: 69-75. 10.1093/embo-reports/kvf008.
Cervantes S, Yamaguchi TP, Hebrock M: A non-canonical Wnt pathway mediated by Wnt5a is required for midgut elongation. Dev Biol. 2007, 306: 419-420. 10.1016/j.ydbio.2007.03.651.
Kestler HA, Kuhl M: From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc Lond B Biol Sci. 2008, 363: 1333-1347. 10.1098/rstb.2007.2251.
Ghosh S, Roy S, Seguin C, Bryant SV, Gardiner DM: Analysis of the expression and function of Wnt-5a and Wnt-5b in developing and regenerating axolotl (Ambystoma mexicanum) limbs. Dev Growth Differ. 2008, 50: 289-297. 10.1111/j.1440-169X.2008.01000.x.
Stoick-Cooper CL, Weidinger G, Riehle KJ, Hubbert C, Major MB, Fausto N, Moon RT: Distinct Wnt signaling pathways have opposing roles in appendage regeneration. Development. 2007, 134: 479-489. 10.1242/dev.001123.
Mount JG, Muzylak M, Allen S, Althnaian T, McGonnell IM, Price JS: Evidence that the canonical Wnt signalling pathway regulates deer antler regeneration. Dev Dyn. 2006, 235: 1390-1399. 10.1002/dvdy.20742.
Lin G, Slack JM: Requirement for Wnt and FGF signaling in Xenopus tadpole tail regeneration. Dev Biol. 2008, 316: 323-335. 10.1016/j.ydbio.2008.01.032.
Hay ED: Electron microscope observations of muscle dedifferentiation in regeneration of Amblystoma limbs. Dev Biol. 1959, 1: 555-585. 10.1016/0012-1606(59)90018-1.
Morzlock FV, Stocum DL: Patterns of RNA synthesis in regenerating limbs of the adult newt, Triturus viridescens. Dev Biol. 1971, 24: 106-118. 10.1016/0012-1606(71)90049-2.
Trojer P, Reinberg D: Histone lysine demethylases and their impact on epigenetics. Cell. 2006, 125: 213-217. 10.1016/j.cell.2006.04.003.
Swigut T, Wysocka J: H3K27 demethylases, at long last. Cell. 2007, 131: 29-32. 10.1016/j.cell.2007.09.026.
Kolli S, Zito CI, Mossink MH, Wiemer EA, Bennett AM: The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem. 2004, 279: 29374-29385. 10.1074/jbc.M313955200.
Steiner E, Holzmann K, Elbling L, Micksche M, Berger W: Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets. 2006, 7: 923-934. 10.2174/138945006778019345.
Steiner E, Holzmann K, Pirker C, Elbling L, Micksche M, Sutterluty H, Berger W: The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals. J Cell Sci. 2006, 119: 459-469. 10.1242/jcs.02773.
Yoshinari N, Ishida T, Kudo A, Kawakami A: Gene expression and functional analysis of zebrafish larval fin fold regeneration. Dev Biol. 2009, 325: 71-81. 10.1016/j.ydbio.2008.09.028.
Sharma M, Naslavsky N, Caplan S: A role for EHD4 in the regulation of early endosomal transport. Traffic. 2008, 9: 995-1018. 10.1111/j.1600-0854.2008.00732.x.
Kuo HJ, Tran NT, Clary SA, Morris NP, Glanville RW: Characterization of EHD4, an EH domain-containing protein expressed in the extracellular matrix. J Biol Chem. 2001, 276: 43103-43110. 10.1074/jbc.M106128200.
Stocum DL: Wound Repair, Regeneration and Artificial Tissues. 1995, Austin, TX: RG Landes
Vethamany-Globus S: A critical analysis of hormone action in newt limb regeneration: a possible opiate (β-endorphin) connection. Regeneration and Development. Edited by: Inoue SC, Shirai T, Egar MW, Aiyama S, Geraudie J, Nobunaga T, Sato NL. 1988, Maebashi, Japan: Okada Printing and Publishing, 661-674.
Vethamany-Globus S: Immunohistochemical localization of β-endorphin-like material in the urodele and anuran amphibian tissues. Gen Comp Endocrinol. 1989, 75: 271-279. 10.1016/0016-6480(89)90080-4.
Peadon AM, Singer M: The blood vessels of the regenerating limb of the adult newt, Triturus. J Morphol. 1966, 118: 79-89. 10.1002/jmor.1051180106.
Kim JW, Dang CV: Multifaceted roles of glycolytic enzymes. Trends Biochem Sci. 2005, 30: 142-150. 10.1016/j.tibs.2005.01.005.
Funasaka T, Yanagawa T, Hogan V, Raz A: Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J. 2005, 19: 1422-1430. 10.1096/fj.05-3699com.
Mylotte LA, Duffy AM, Murphy M, O'Brien T, Samali A, Barry F, Szegezdi E: Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells. 2008, 26: 1325-1336. 10.1634/stemcells.2007-1072.
Solorzano L, Rieber MS, Medina JD, Rieber M: Decreased glycolytic metabolism accelerates apoptosis in response to 2-acetyl furanonaphthoquinone in K1735 melanoma irrespective of bcl-2 overexpression. Cancer Biol Ther. 2005, 4: 329-335. 10.4161/cbt.4.3.1642.
Naviaux RK, Le TP, Bedelbaeva K, Leferovich J, Gourevitch D, Sachadyn P, Zhang XM, Clark L, Heber-Katz E: Retained features of embryonic metabolism in the adult MRL mouse. Mol Genet Metab. 2009, 96: 133-144. 10.1016/j.ymgme.2008.11.164.
Warburg O, Posener K, Negelein E: Uber den Stoffwechsel der Tumoren. Biochemische Zeitschrift. 1924, 152: 319-344.
Khurana NK, Niemann H: Energy metabolism in preimplantation bovine embryos derived in vitro or in vivo. Biol Reprod. 2000, 62: 847-856. 10.1095/biolreprod62.4.847.
Hunt TK, Aslam RS, Beckert S, Wagner S, Ghani QP, Hussain MZ, Roy S, Sen CK: Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal. 2007, 9: 1115-1124. 10.1089/ars.2007.1674.
Needham AE: Regeneration and Wound Healing. 1952, London, UK: Methuen
Schmidt AJ: The Molecular Basis of Regeneration: Enzymes. Illinois Monographs in Medical Sciences. Edited by: Kirch ER, Marberger JP, Reynolds SRM, Winzler RJ. 1966, Urbana, IL: University of Illinois Press, 6:
Reid MB: Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand. 1998, 162: 401-409. 10.1046/j.1365-201X.1998.0303f.x.
Maden M: Retinoic acid and its receptors in limb regeneration. Semin Cell Dev Biol. 1997, 8: 445-453. 10.1006/scdb.1997.0168.
Mescher AL, White GW, Brokaw JJ: Apoptosis in regenerating and denervated, nonregenerating urodele forelimbs. Wound Repair Regen. 2000, 8: 110-116. 10.1046/j.1524-475x.2000.00110.x.
Atkinson DL, Stevenson TJ, Park EJ, Riedy MD, Milash B, Odelberg SJ: Cellular electroporation induces dedifferentiation in intact newt limbs. Dev Biol. 2006, 299: 257-271. 10.1016/j.ydbio.2006.07.027.
Kaufman RJ: Orchestrating the unfolded protein response in health and disease. J Clin Invest. 2002, 110: 1389-1398.
Ellgaard L, Helenius A: Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol. 2003, 4: 181-191. 10.1038/nrm1052.
Wagener FA, van Beurden HE, Hoff von den JW, Adema GJ, Figdor CG: The heme-heme oxygenase system: a molecular switch in wound healing. Blood. 2003, 102: 521-528. 10.1182/blood-2002-07-2248.
Su AI, Guidotti LG, Pezacki JP, Chisari FV, Schultz PG: Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci USA. 2002, 99: 11181-11186. 10.1073/pnas.122359899.
Crews L, Gates PB, Brown R, Joliot A, Foley C, Brockes JP, Gann AA: Expression and activity of the newt Msx-1 gene in relation to limb regeneration. Proc Biol Sci. 1995, 259: 161-171. 10.1098/rspb.1995.0024.
Shimizu-Nishikawa K, Tsuji S, Yoshizato K: Identification and characterization of newt rad (ras associated with diabetes), a gene specifically expressed in regenerating limb muscle. Dev Dyn. 2001, 220: 74-86. 10.1002/1097-0177(20010101)220:1<74::AID-DVDY1090>3.0.CO;2-Q.
Cadinouche MZ, Liversage RA, Muller W, Tsilfidis C: Molecular cloning of the Notophthalmus viridescens radical fringe cDNA and characterization of its expression during forelimb development and adult forelimb regeneration. Dev Dyn. 1999, 214: 259-268. 10.1002/(SICI)1097-0177(199903)214:3<259::AID-AJA9>3.0.CO;2-G.
Burgess AM: The developmental potentialities of regeneration blastema cell nuclei as determined by nuclear transplantation. J Embryol Exp Morphol. 1967, 18: 27-41.
Stocum DL: The urodele limb regeneration blastema. Determination and organization of the morphogenetic field. Differentiation. 1984, 27: 13-28. 10.1111/j.1432-0436.1984.tb01403.x.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007, 131: 861-872. 10.1016/j.cell.2007.11.019.
Maki N, Suetsugu-Maki R, Tarui H, Agata K, Del Rio-Tsonis K, Tsonis PA: Expression of stem cell pluripotency factors during regeneration in newts. Dev Dyn. 2009, 238: 1613-1616. 10.1002/dvdy.21959.
Tanaka E, Galliot B: Triggering the regeneration and tissue repair programs. Development. 2009, 136: 349-353. 10.1242/dev.031682.
Pirot P, Naamane N, Libert F, Magnusson NE, Orntoft TF, Cardozo AK, Eizirik DL: Global profiling of genes modified by endoplasmic reticulum stress in pancreatic β cells reveals the early degradation of insulin mRNAs. Diabetologia. 2007, 50: 1006-1014. 10.1007/s00125-007-0609-0.
Kim SJ, Hwang SG, Kim IC, Chun JS: Actin cytoskeletal architecture regulates nitric oxide-induced apoptosis, dedifferentiation, and cyclooxygenase-2 expression in articular chondrocytes via mitogen-activated protein kinase and protein kinase C pathways. J Biol Chem. 2003, 278: 42448-42456. 10.1074/jbc.M304887200.
Yu S-M, Lee W-K, Yoon E-K, Lee J-H, Lee S-R, Kim S-J: Src kinase regulates nitric oxide-induced dedifferentiation and cyclooxygenase-2 expression in articular chondrocytes via p38 kinase-dependent pathway. Immune Network. 2006, 6: 204-210.
Tsang KY, Chan D, Cheslett D, Chan WC, So CL, Melhado IG, Chan TW, Kwan KM, Hunziker EB, Yamada Y, Bateman JF, Cheung KM, Cheah KS: Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol. 2007, 5: e44-10.1371/journal.pbio.0050044.
Abrahan CE, Insua MF, Politi LE, German OL, Rotstein NP: Oxidative stress promotes proliferation and dedifferentiation of retina glial cells in vitro. J Neurosci Res. 2009, 87: 964-977. 10.1002/jnr.21903.
Del Rio-Tsonis K, Tsonis PA: Eye regeneration at the molecular age. Dev Dyn. 2003, 226: 211-224. 10.1002/dvdy.10224.
Moshiri A, Close J, Reh TA: Retinal stem cells and regeneration. Int J Dev Biol. 2004, 48: 1003-1014. 10.1387/ijdb.041870am.
Yoshii C, Ueda Y, Okamoto M, Araki M: Neural retinal regeneration in the anuran amphibian Xenopus laevis post-metamorphosis: transdifferentiation of retinal pigmented epithelium regenerates the neural retina. Dev Biol. 2007, 303: 45-56. 10.1016/j.ydbio.2006.11.024.
Sekiguchi-Tonosaki M, Obata M, Haruki A, Himi T, Kosaka J: Acetylcholine induces Ca2+ signaling in chicken retinal pigmented epithelial cells during dedifferentiation. Am J Physiol Cell Physiol. 2009, 296: 1195-1206. 10.1152/ajpcell.00423.2008.
Sakai H, Saito T: Na+ and Ca2+ channel expression in cultured newt retinal pigment epithelial cells: comparison with neuronal types of ion channels. J Neurobiol. 1997, 32: 377-390. 10.1002/(SICI)1097-4695(199704)32:4<377::AID-NEU2>3.0.CO;2-3.
Ulianich L, Garbi C, Treglia AS, Punzi D, Miele C, Raciti GA, Beguinot F, Consiglio E, Di Jeso B: ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells. J Cell Sci. 2008, 121: 477-486. 10.1242/jcs.017202.
Faitar SL, Sossey-Alaoui K, Ranalli TA, Cowell JK: EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis. Exp Cell Res. 2006, 312: 2325-2335. 10.1016/j.yexcr.2006.03.032.
Eldridge AG, Loktev AV, Hansen DV, Verschuren EW, Reimann JD, Jackson PK: The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1. Cell. 2006, 124: 367-380. 10.1016/j.cell.2005.10.038.
Westlake CJ, Junutula JR, Simon GC, Pilli M, Prekeris R, Scheller RH, Jackson PK, Eldridge AG: Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc Natl Acad Sci USA. 2007, 104: 1236-1241. 10.1073/pnas.0610500104.
Dabbeekeh JT, Faitar SL, Dufresne CP, Cowell JK: The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11. Oncogene. 2007, 26: 2804-2808. 10.1038/sj.onc.1210081.
Thornton CS: The histogenesis of muscle in the regenerating forelimb of larval Ambystoma punctatum. J Morphol. 1938, 62: 17-46. 10.1002/jmor.1050620104.
Litwiller R: Mitotic index and size in regenerating amphibian limbs. J Exp Zool. 1939, 82: 273-286. 10.1002/jez.1400820206.
Suzuki M, Satoh A, Ide H, Tamura K: Transgenic Xenopus with prx1 limb enhancer reveals crucial contribution of MEK/ERK and PI3K/AKT pathways in blastema formation during limb regeneration. Dev Biol. 2007, 304: 675-686. 10.1016/j.ydbio.2007.01.019.
Christensen RN, Weinstein M, Tassava RA: Expression of fibroblast growth factors 4, 8, and 10 in limbs, flanks, and blastemas of Ambystoma. Dev Dyn. 2002, 223: 193-203. 10.1002/dvdy.10049.
Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J, Hunt DF, Funabiki H, Allis CD: Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature. 2005, 438: 1116-1122. 10.1038/nature04219.
Terada Y: Aurora-B/AIM-1 regulates the dynamic behavior of HP1α at the G2-M transition. Mol Biol Cell. 2006, 17: 3232-3241. 10.1091/mbc.E05-09-0906.
Fischer T, Cui B, Dhakshnamoorthy J, Zhou M, Rubin C, Zofall M, Veenstra TD, Grewal SI: Diverse roles of HP1 proteins in heterochromatin assembly and functions in fission yeast. Proc Natl Acad Sci USA. 2009, 106: 8998-9003. 10.1073/pnas.0813063106.
Sabbattini P, Canzonetta C, Sjoberg M, Nikic S, Georgiou A, Kemball-Cook G, Auner HW, Dillon N: A novel role for the aurora B kinase in epigenetic marking of silent chromatin in differentiated postmitotic cells. EMBO J. 2007, 26: 4657-4669. 10.1038/sj.emboj.7601875.
Amabile G, D'Alise AM, Iovino M, Jones P, Santaguida S, Musacchio A, Taylor S, Cortese R: The aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts. Cell Death Differ. 2009, 16: 321-330. 10.1038/cdd.2008.156.
Suzuki M, Yakushiji N, Nakada Y, Satoh A, Ide H, Tamura K: Limb regeneration in Xenopus laevis froglet. Sci World J. 2006, 6 (Suppl 1): 26-37.
Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE: Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res. 2005, 4: 1442-1450. 10.1021/pr050109b.
Limpert E, Stahel WA, Abbot M: Log-normal distributions across the sciences: keys and clues. Biosci. 2001, 51: 341-352. 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2.
Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003, 19: 185-193. 10.1093/bioinformatics/19.2.185.
Reiner A, Yekutieli D, Benjamini Y: Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics. 2003, 19: 368-375. 10.1093/bioinformatics/btf877.
National Center for Biotechnology Information. [http://www.ncbi.nlm.nih.gov/]
Human Protein Reference Database. [http://hprd.org/]
Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.
Saldanha AJ: Java Treeview - extensible visualization of microarray data. Bioinformatics. 2004, 20: 3246-3248. 10.1093/bioinformatics/bth349.
We thank Teri Belecky-Adams and Anthony Mescher for their suggestions on figures and text. We gratefully acknowledge the support of the W M Keck Foundation via a grant to DLS and JAC.
Project conception and experimental design: DLS, FS, NR, DJ. Staging and tissue harvest: DLS, NR, FS. Development and application of LC-MS/MS protein analysis: MW. Protein biological process/function/location search: DJ, NR, BL, DJM, HLDN, BS. Bioinformatics tools and analysis: DJ, MP. Data analysis and interpretation: NR, DJ, DJM, BL, DLS. Axolotl EST sequence matching: SRV. Histology, immunostaining, densitometry: NR, DJM. Manuscript writing: DLS, NR, DJ. Manuscript editing and critique: FS, BL, MWK, JAC.
Electronic supplementary material
Additional file 1: Statistically significant priority 1 and 2 proteins. Each peptide is listed with its priority number, accession number, gene name, protein name, peptide sequence and maximum fold change (MFC). Proteins identified by axolotl ESTdb are in bold. (XLS 97 KB)
Additional file 2: Fold changes of 309 priority 1 and 2 proteins at 1, 4 and 7 days post amputation (dpa) relative to control for all categories of biological process. Minus indicates negative fold change; otherwise the fold change is positive. NC = no change. (XLS 79 KB)
Authors’ original submitted files for images
About this article
Cite this article
Rao, N., Jhamb, D., Milner, D.J. et al. Proteomic analysis of blastema formation in regenerating axolotl limbs . BMC Biol 7, 83 (2009). https://doi.org/10.1186/1741-7007-7-83
- Unfold Protein Response
- Canonical Pathway
- Major Vault Protein
- Blastema Cell
- Retinal Pigment Epithelial Cell